In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully
Sanya Sukduang
Advertisement
Articles by Sanya Sukduang
Advertisement
Latest Updated Articles
- Follow-on Biologics: A Patent Litigation Perspective
Published: August 22nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FDA Approves Novo Nordisk’s Wegovy Pill, Marking First Oral GLP-1 for Weight Management
2
Yusen Logistics Completes Walden Health Acquisition, Expanding European Healthcare Logistics Platform
3
Leveraging Global Scale and Collaboration for Pharma Supply Chain Innovation
4
Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition
5